Modelling measles re-emergence as a result of waning of immunity in vaccinated populations

Vaccine

Volumn 21, Issue 31, 2003, Pages 4597-4603

  Mossong, Joël ^a   Muller, Claude P ^a  

^a LABORATOIRE NATIONAL DE SANTÉ   (Luxembourg)

Author keywords

Mathematical model; Measles; Vaccination; Waning immunity

Indexed keywords

MEASLES VACCINE;

AGE DISTRIBUTION; ARTICLE; COMPARATIVE STUDY; DISEASE MODEL; DISEASE SIMULATION; HEALTH STATISTICS; HUMAN; IMMUNITY; IMMUNOLOGICAL TOLERANCE; INFECTION PREVENTION; MATHEMATICAL MODEL; MEASLES; MEASLES VACCINATION; POPULATION RESEARCH; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 0142199965     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(03)00449-3     Document Type: Article

References (20)

1. World Health Organization. World health report 1999: making a difference. Geneva, Switzerland: World Health Organization; 1999.
2. World Health Organization. Global measles mortality reduction and regional elimination strategic plan 2001-2005. Geneva, Switzerland: World Health Organization; 2001.
3. Christenson B., Bottiger M. Measles antibody - comparison of long-term vaccination titers, early vaccination titers and naturally acquired-immunity to and booster effects on the measles virus. Vaccine. 12:1994;129-133.
4. Chen R.T., Markowitz L.E., Albrecht P.et al. Measles antibody - revaluation of protective titers. J. Infect. Dis. 162:1990;1036-1042.
5. Helfand R.F., Kim D.K., Gary H.E.et al. Non-classic measles infections in an immune population exposed to measles during a college bus trip. J. Med. Virol. 56:1998;337-341.
6. Muller C.P., Fack F., Damien B., Bouche F.B. Immunogenic measles antigens expressed in plants: role as an edible vaccine for adults. Vaccine. 21(7-8):2003;816-819.
7. Muller C.P. Measles elimination: old and new challenges? Vaccine. 19(17-19):2001;2258-2261.
8. Damien B., Huiss S., Schneider F., Muller C.P. Estimated susceptibility to asymptomatic secondary immune response against measles in late convalescent and vaccinated persons. J. Med. Virol. 56(1):1998;85-90.
9. van den Hof S., Berbers G.A., de Melker H.E., Conyn-van Spaendonck M.A. Sero-epidemiology of measles antibodies in the Netherlands, a cross-sectional study in a national sample and in communities with low vaccine coverage. Vaccine. 18(9-10):1999;931-940.
10. Markowitz L.E., Preblid S.R., Fine P.E.M., Orenstein W.A. Duration of live measles vaccine-induced immunity. Pediatr. Infect. Dis. J. 9:1990;101-110.
11. Mossong J., Muller C.P. Estimation of the basic reproduction number of measles during an outbreak in a partially vaccinated population. Epidemiol. Infect. 124:2000;273-278.
12. Edmonson M.B., Addiss D.G., McPherson J.T.et al. Mild measles and secondary vaccine failure during a sustained outbreak in a highly vaccinated population. JAMA. 263:1990;2466-2467.
13. Aaby P., Bukh J., Leerhoy J.et al. Vaccinated children get milder measles infection - a community study from Guinea-Bissau. J. Infect. Dis. 154:1986;858-863.
14. Mossong J., Nokes D.J., Edmunds W.J., Cox M.J., Ratnam S., Muller C.P. Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity. Am. J. Epidemiol. 150(11):1999;1238-1249.
15. Anderson RM, May EM. Infectious diseases of humans: dynamics and control. Oxford: Oxford University Press; 1991.
16. Mossong J. Modeling measles in vaccinated populations. PhD thesis, University of Warwick; 2000.
17. McLean A.R., Anderson R.M. Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidem. Inf. 100:1988;419-442.
18. Bautista-Lopez N., Ward B.J., Mills E., McCormick D., Martel N., Ratnam S. Development and durability of measles antigen-specific lymphoproliferative response after MMR vaccination. Vaccine. 18(14):2000;1393-1401.
19. Whittle H.C., Aaby P., Samb B., Jensen H., Bennett J., Simondon F. Effect of subclinical infection on maintaining immunity against measles in vaccinated children in West Africa. Lancet. 353(9147):1999;98-102.
20. Pütz M.M., Bouche F.B., de Swart R.L., Muller C.P. Experimental vaccines against measles in a world of changing epidemiology. Int. J. Parasitol. 33(5-6):2003;525-545.